help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Rienzo, G.
Right arrow Articles by Minucci, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Rienzo, G.
Right arrow Articles by Minucci, S.
Endocrinology Vol. 142, No. 7 3231-3238
Copyright © 2001 by The Endocrine Society


ARTICLES

Isolation and Characterization of a Novel Member of the Relaxin/Insulin Family from the Testis of the Frog Rana esculenta1

Gianluca de Rienzo2, Francesco Aniello2, Margherita Branno2 and Sergio Minucci2

Dipartimento di Medicina Sperimentale-Sezione di Fisiologia Umana e Funzioni Biologiche Integrate "F. Bottazzi" (G.D.R., S.M.), Seconda Università degli Studi di Napoli-Via Costantinopoli, 16 80138 Napoli, Italy; and Laboratorio di Biochimica e Biologia Molecolare (F.A., M.B.), Stazione Zoologica "A. Dohrn"- Villa Comunale 121 80132 Napoli, Italy

Address all correspondence and requests for reprints to: Dr. Sergio Minucci, Dipartimento di Medicina Sperimentale-Sezione di Fisiologia Umana e Funzioni Biologiche Integrate "F. Bottazzi" Seconda Università degli Studi di Napoli-Via Costantinopoli, 16 80138 Napoli, Italy. E-mail: sergio.minucci{at}unina2.it


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A complementary DNA (cDNA) encoding a frog relaxin/insulin member family (fRLX) from testis cDNA library was isolated and characterized. The fRLX cDNA predicted a 155-amino acid protein with a low homology to mammalian RLF and relaxin. Northern blot analysis revealed a single transcript expressed in the interstitial compartment, RT-PCR, evidenced that fRLX is expressed at low levels in the oviduct and ovary too. The predicted mature fRLX protein, composed of the signal peptide, B, C, and A domains, has conserved amino acid sequences in the characteristic functional domains. A different expression of the transcript was found during the frog reproductive cycle, with a peak in Spring. After administration of ethane dimethane sulfonate, by in situ hybridization, fRLX messenger RNA disappeared from the interstitial compartment and reappeared again at the time of generating of a new population of Leydig cells (LC), strongly indicating that LC are the interstitial cell type expressing fRLX. Preliminary results obtained by in situ hybridization, performed on testis of hypophysectomized frogs evidenced a pituitary control of fRLX expression. This study is the first cloning of a relaxin/insulin family member in a nonmammalian vertebrate. In addition, because fRLX expression changes during the annual cycle suggesting its involvement in spermatogenesis, fRLX may be considered a new marker for the study of spermatogenesis in the Rana esculenta.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
WE HAVE isolated from the testis of the frog Rana esculenta, a complementary DNA (cDNA) clone coding for a novel relaxin/insulin family member (fRLX) that present a modest homology with mammalian relaxin and relaxin-like factor (RLF). RLF was originally isolated from porcine, human and mouse testis cDNA libraries (1, 2, 3), whereas relaxin is a classical endocrine hormone produced by the ovary, placenta, or uterus in many mammalian species (4).

Recently RLF has been isolated and characterized in other mammalian species (5, 6, 7, 8). Its sequence in all species shows the common B-C-A heteromeric structural organization in which the B and A domain are covalently linked by two intradomain disulfide bonds and in the B domain the highly conserved R-XXX-R relaxin receptor binding motif is present (9).

Several studies showed that RLF is expressed in fetal and adult testis (1, 3) and, in particular at a high level in the testicular Leydig cells of all mammalian species studied so far (9). It has also been detected at a low level in the placenta (10), theca cells, granulosa cells, corpus luteum, and ovarian stroma (11, 12). The expression of RLF in reproductive tissues suggests a potential involvement in reproduction; this is supported by the observation that transcription of the gene is mediated by steroidogenic factor I (SF-I) (13).

The functional role of the relaxin/insulin proteins in the testis is still not fully understood, although male mice with an inactive RLF gene show altered spermatogenesis (14) and male RLF-knockout mice exhibit bilateral cryptorchidism that results in abnormal spermatogenesis and infertility, probably due to a failure of the testis to descend properly during fetal development (15, 16).

No information about RLF expression is found in nonmammalian species. In the present study we report, for the first time, the cloning of a novel relaxin/insulin family member in the testis of an anuran, Rana esculenta, a seasonal breeder with a spermatogenic cycle regulated by endocrine and environmental factors and a cystic organization of its testis that favors the study of spermatogenesis (17).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Fifty male adult frogs of Rana esculenta were supplied monthly by a local dealer, and five additional female adult frogs were captured in January. The animals were killed by decapitation under anesthesia (MS-222 Sigma, St. Louis, MO) and the testes, Harderian gland (HG), kidneys, livers, brains, ovaries, oviducts, and muscles were dissected, quickly frozen by immersion in liquid nitrogen and stored at -80 C until RNA extraction. In addition, five testes were fixed in Bouin’s fluid, processed for histological observation, and 5 µm paraffin section were stained with hematoxylin-eosin for a monthly check of the testicular activity.

Preparation of poly (A)+ RNA
Total RNA from the testes, HGs, kidneys, livers, brains, muscles, ovary, and oviduct of the frog Rana esculenta were prepared with a modification of Chomczynski and Sacchi procedure (18). Poly (A)+ was purified by oligo (dT) cellulose chromatography (19).

Isolation and sequencing of tissue-specific cDNA clones
The total cDNA inserts derived from 3 x 106 pfu from the two libraries prepared from poly (A)+ messenger RNA (mRNA) extracted from the testis and Harderian gland (HG) as described by Aniello et al. (20) were rescued as Bluescript plasmids (SK+) by a helper phage mediate in vivo excision as described by the manufacturer (Stratagene, Cambridge, UK).

The maxiexcision of the HG cDNA library was used to prepare the probe to screen the maxiexcision of testis library.

In particular, 10 µg of plasmidic DNA obtained from HG cDNA library maxiexcision were digested with cloning restriction enzyme (EcoRI-XhoI) and the digestion product containing insert of 0.5–2.5 kb was labeled with the random primer method using a mixture of [{alpha}32P]-dCTP and [{alpha}32P]-dATP (Amersham Pharmacia Biotech, Aylesburg, UK).

A quantity of 2 x 104 testis library plasmidic clones (1000 colonies/plate) were plated on LB-ampicilline agar plates (50 µg/ml) and incubated overnight at 37 C. Colonies containing the pBluescript with the cloned DNA inserts were transferred on nylon filters (Colony/Plaque Screen NEN Life Science Products, Boston) and hybridized with the probe described above in 5x SSC, 5x Denhardt’s, 100 µg/ml salmon sperm DNA and 50 mM sodium phosphate at pH 7.0 overnight at 65 C. After the hybridization, plasmidic DNA was prepared from 14 negative clones as described (19). The directionated inserts (5'EcoRI- 3'XhoI) were sequenced on both strands by dideoxinucleotide procedure (21).

5'-RACE-PCR
The 5'-RACE-PCR was performed using 1 µg of total RNA prepared from March testis according to the manufacturer’s instructions (Life Technologies, Inc., Paisley, UK) employing the poly (A)+ RNA from testis, the cDNA-specific primers (test 1C: 5'-cacaggacatgacaactgtccgaata-3', test 1D: 5'-acatccatgccttggcaccaaaccg-3', test 1F: 5'-cggtatagccaacgtaaga-3') and the universal primer (5'-ggccacgcgtcgactagtac-3', Life Technologies, Inc.). RACE-PCR was run for 35 cycles at an annealing temperature of 68 C. The PCR product was separated on 1% agarose gel, purified by QIAGEN gel extraction kit (QIAGEN, Hilden, Germany) and cloned into the pGEM-T vector (Promega Corp., Heidelberg, Germany). Sequence analysis of PCR-amplified cDNA was performed as describe above.

Phylogenetic analysis
To trace the primary sequence relationships of fRLX with other known RLF and relaxin, a phylogenetic analysis was performed using amino acid sequence of seven RLFs and seven relaxins. Sequences were managed and aligned using BioEdit version 4.5.8 software (22). For the phylogenetic tree a Kimura 2p distance matrix was obtained and the tree was constructed using UPGMA (Unweighted Pair-group Method using Arithmetic Averages) clustering procedure through the Neighbor joining method using the PHYLIP computer package (23). The robustness of the phylogenetic hypothesis was tested by bootstrapping. To assess branch reliability, all bootstrap analyses of amino acids involved 500 replications of the data.

Northern blot analysis
Total RNA (20 µg for each sample) was fractionated by electrophoresis in 2.2 M formaldehyde on 1% agarose gel and then transferred to a nitrocellulose membrane by overnight capillary blotting. The filters were prehybridized for 5–6 h at 65 C in 5x SSC, 5x Denhardt’s, 100 µg/ml salmon sperm DNA and 50 mM sodium phosphate at pH 7.0 and hybridized to test 1 probe (2 x 106 cpm/ml) at 65 C overnight. The filters were washed twice for 30 min at 65 C in 0.2x SSC and 0.1% SDS and finally were exposed to x-ray film (HR-H, Fuji Photo Film Co., Ltd., Tokyo, Japan).

RT-PCR
fRLX and frog heat-shock protein 90 (HSP90) mRNA levels were measured by RT-PCR amplification.

First-strand cDNA was synthesized using 5 µg total RNA from a January ovary, oviduct and testis, 500 ng/µl oligo(dT)18 primer (Promega Corp., Heidelberg, Germany) and 200 U Superscript II RT enzyme (Life Technologies, Inc.) in a total volume of 20 µl according to the manufacturer’s instructions (Life Technologies, Inc.). Three microliters of this cDNA template was then used for the PCR (50 µl volume) with 1.5 mM MgCl2, 1 x PCR buffer (10 mM Tris-HCl, pH 9.0, 50 mM KCl, and 0.1% TritonX-100), 0.5 U Taq DNA polymerase (Promega Corp., Heidelberg, Germany) and 10 pmol oligonucleotide primers (fRLX forward primer: 5'-tgtatgcagagagccacat-3', fRLX reverse primer: 5'-gagtgcttgctctgcagac-3', HSP90 forward primer: 5'-tggctggacagctaacatg-3', HSP90 reverse primer: 5'-tcaggacatcacatactggc-3'). The RT-PCR product sizes were 265 bp for fRLX and 723 bp for HSP90.

An appropriate region of HSP90 cDNA was used as control. Amplifications, carried out for 30 cycles, were as follows: 94 C for 1 min, 53 C for 1 min, and 72 C for 1 min. Amplification products were electrophoresed on 1.5% agarose gel in 1x TAE buffer. Semiquantitative analysis of mRNA levels was carried out by the GEL DOC 1,000-UV fluorescent gel documentation system (Bio-Rad Laboratories, Inc., Hercules, CA).

In situ hybridization
Frog testes were perfusion fixed in Bouin’s fluid for 24 h at room temperature. The tissues were dehydrated and embedded in paraffin. Five-micrometer paraffin sections were dewaxed in xilol twice for 10 min each time and transferred through descending grades of ethanol to diethilpyrocarbonate-treated PBS for 5 min. The sections were prefixed in 4% paraformaldehyde in 0.5 M NaCl, 0.1 M MOPS, pH 7.5, for 30 min at room temperature, then washed in PBS. This was followed by incubation in 10 µg/ml proteinase K in 100 mM Tris-HCl, pH 7.2, and 1 mM EDTA for 10 min at room temperature. The sections were postfixed in 4% paraformaldehyde in 0.5 M NaCl, 0.1 M MOPS, pH 7.5, for 30 min at room temperature. Slides were washed in PBS for 5 min, then transferred in 2 x SSC for 3 min. Before hybridization, the sections were kept in Tris-glycine buffer for 45 min. The hybridization solution comprised 40% deionized formamide, 5x SSC, 1x Denhardt’s solution, 100 µg/ml sonicated salmon testes, 100 µg/ml transfer RNA, and 80 ng digoxigenin-labeled complementary RNA (cRNA) probe (see below). Eighty microliters of hybridization solution were added on each slide. Hybridization proceeded overnight at 60 C in a moist chamber. Slides were rinsed 3 times in 5 x SSC for 20 min each, then washed in posthybridization buffer (0.5x SSC, 20% deionized formamide) for 40 min at 60 C. Ribonuclease (RNase) A digestion was then carried out to remove unspecifically bound single-stranded cRNA probe. Sections were incubated for 30 min at 37 C in RNase buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 7, 1 mM EDTA) containing 100 µg/ml RNase A, and rinsed in RNase buffer without the enzyme for 15 min at 37 C. The slides were washed in posthybridization buffer for 30 min at 60 C and rinsed in 2 x SSC for 30 min at room temperature. The sections were incubated in 1% blocking solution [1% blocking reagent (Roche Diagnostics, Basel, Switzerland) in MBT buffer, 0.1 M maleic acid, 0.15 M NaCl, pH 7.5] for 10 min. The slides were incubated overnight at 4 C with an alkaline phoshatase-conjugated sheep anti digoxigenin antibody (Roche Diagnostics) diluted 1:2000 in MBT buffer. Sections were rinsed 4 times in TBS for 10 min each and then in solution B (0.1% Tween-20, 0.5 mg/ml levamisol) for 10 min before the color detection substrate solution was applied [1 ml BM purple (Roche Diagnostics), 10 µl 100x solution B per slide], sections were incubated overnight in the dark at room temperature, and the reaction was stopped by rinsing the slides in PBS, 1 mM EDTA for 10 min at room temperature. Sections were dehydrated and mounted. The 1222-bp test1 pBluescript II SK+ clone was linearized with either EcoRI or XhoI to create antisense or sense cRNA probes using T7 or T3 RNA polymerases, respectively. The sense (control) and antisense cRNA probes were prepared by in vitro transcription using (digoxigenin-UTP Roche Diagnostics) exactly as recommended by the manufacturer.

Ethane 1,2-dimethane sulfonate (EDS) treatment
In February, adult frogs (n = 25) were divided into three groups as follows: 1) 10 animals that received a single injection of EDS [100 mg/kg body weight in dimethyl sulfoxide (DMSO)-water, 1:3 vol/vol]; 2) 10 animals that received a single injection of DMSO; 3) 5 animals were used as initial controls at the beginning of the treatment. The EDS- and DMSO-injected frogs were killed on days 4 and 28 (5 animals/group/each time) after treatment and the testes were removed and fixed for in situ hybridization.

Hypophysectomized (PDX) animals
In January, adult frogs (n = 25) were divided into two groups as follows: 1) 20 animals were hypophysectomized (24) and kept in captivity with food and meal ad libitum for 30 days; 2) 5 animals were kept in captivity with food and meal ad libitum for 30 days. At the end of the experiment, the testes of all the animals were removed and fixed for in situ hybridization.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cloning and characterization of fRLX cDNA
To identify frog testis-specific genes, we performed an experimental technique using two different cDNA libraries, from testis and Harderian gland (HG) of Rana esculenta. The testis library was screened with an HG heterogeneous probe representing the total inserts of HG library cDNAs. With this method we have been able to isolate 14 negative clones, probably expressed only in the testis. We report here on the analysis of clone test 1, corresponding to a testis-specific gene. Sequence analysis of this clone showed that it contains an insert of 1222 bp, but no start codon was present. To obtain the remaining 5'coding sequence a 5'-rapid amplification of cDNA ends (5'-RACE) by PCR was performed. The PCR fragment was found to contain the remaining 5'coding region preceded by 31 bp of untranslated region (UTR). The total length of the assembled cDNA of Rana esculenta test 1 was found to be 1462 bp. It contains an open reading frame with the start codon at position 32 and the stop codon at position 499. The 3'-UTR is 963 bp including 18 nucleotides of poly (A) tail (Fig. 1Go). The sequence following the first methionine potentially encodes a protein of 155 amino acids residues. The deduced amino acid sequence was compared with all nonredundant GenBank entries and showed a low similarity to RLF and relaxin from different species; for this reason, test 1 was named "frog relaxin" (fRLX). The sequence shows a low identity at amino acids level with RLF and relaxin known proteins (Table 1Go). Although the low value of identity, fRLX prepolypeptide contains the classical B-C-A domain configuration present in all the insulin/relaxin family proteins. Restricting the comparison among the B and A domains, forming the mature proteins, the values are higher (Table 1Go), showing that in all the members of the family the cystein motifs present in the A and B domains were highly conserved (Fig. 2Go). The A-domain motif is CC X3 C X8 C where XN represents the number of residues comprising no amino acids other than cystein. The B-domain motif is LCG X10 C (Fig. 2Go).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 1. Nucleotide and amino acid sequence of the frog RLX cDNA. The putative position of the signal peptidase cleavage site is indicated as the possible delineation points for the A, B, and C domains. The consensus receptor binding motif is boxed. The start and stop codon are indicated in bold. The number on the right represents nucleotide residues.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Amino acid homology of frog RLX with mouse, human, and pig RLF and human H1, H2, marsupial, and shark relaxin

 


View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. Multiple alignment of the deduced amino acid sequences of the A and B domain of the fRLX with the mouse, human and pig RLF and human H1, H2, marsupial and shark relaxin. Below the alignment are the conserved B and A chain motifs; h, a hydrophobic residue and C, cysteine. The lengths of the nonconserved sequences linking the B and A chains are indicated in brackets.

 
From our phylogenetic analysis, RLF and relaxin sequences cluster in two separate groups. The fRLX sequence is located at the basis of the two groups, suggesting that it can represent an ancestral form of relaxin and RLF (Fig. 3Go).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 3. Relationship of fRLX to relaxin-like factors and to relaxins isolated from other species. The sequences were aligned and compared with construct a phylogenetic tree by using the UPGMA Kimura method. The numbers indicate bootstrap values from 500 replicates. Bootstrap values are expressed as percentage. Horizontal lines indicates genetic distances. The Accession No. of the sequences reported in the dendogram are: 3851207 (human RLF), 3850653 (marmoset monkey RLF), 1708498 (pig RLF), 3719459 (bovine RLF), 9973367 (rat RLF), 1754739 (mouse RLF), 1071943 (shark relaxin), 1710087 (rabbit relaxin), 1710080 (chimpanzee relaxin 1), 132280 (human relaxin 1), 132309 (pig relaxin), and 2506784 (equine relaxin).

 
fRLX expression
The expression of fRLX gene in different frog tissues was analyzed by a Northern blot using as a probe the test 1 cDNA insert. As shown in Fig. 4AGo, a single positive band is present at high level exclusively in the testis. The size of this band, estimated to be about 1.6 kb using as reference the 18S ribosomal RNA, is very close to that of the total fRLX clone isolated. The amount of RNA on each line was controlled using as a probe the frog ribosomal P1 cDNA (Accession No. AJ298875) (Fig. 4BGo).



View larger version (88K):
[in this window]
[in a new window]
 
Figure 4. A, Northern blot analyses of total RNA extracted from different Rana esculenta tissues hybridized with fRLX probe. T, Testis; HG, harderian gland; L, liver; B, brain; K, kidney; M, muscle. B, The illustrated membrane was rehybridized with a fP1 probe as control for the equivalent loading of RNA.

 
RT-PCR analysis was performed to detect the fRLX expression also in the ovary and in the oviduct. As shown in Fig. 5AGo, a very low signal was evidenced both in the ovary and oviduct (lanes 1 and 2, respectively) compared with the strong signal observed in the testis (lane 3).



View larger version (80K):
[in this window]
[in a new window]
 
Figure 5. A, Northern blot analyses of total RNA extracted from frog testes during the annual cycle hybridized with fRLX probe. J/F, January/February; M/A, March/April; M/J, May/June; J/A, July/August; S/O, September/October; N/D, November/December. B, The illustrated membrane was rehybridized with a fP1 probe as control for the equivalent loading of RNA.

 
From a semiquantitative analysis of mRNA levels, it results that the levels of fRLX mRNA expression in ovary and oviduct are 0.3 and 0.7%, respectively, compared with that of the testis.

Temporal expression of fRLX during spermatogenesis
To examine the expression of fRLX during spermatogenesis, a Northern blot analysis was performed using total RNA from testes of frogs collected twice a month during the annual cycle. fRLX mRNA was detected at very high level during the months of January/February and March/April, whereas it was detected at a low level in May/June and July/August and at the lowest level in September/October (Fig. 6AGo). The amount of RNA on each line was controlled using as a probe the frog ribosomal P1 cDNA (Fig. 6BGo).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 6. A, Agarose gel electrophoresis of RT-PCR products of fRLX mRNA. M, Molecular weight marker VI (Roche Diagnostic); C, control PCR; 1, ovary; 2, oviduct; 3, testis. B, Agarose gel electrophoresis of RT-PCR products of HSP90 (Accession No.: AJ309565) mRNA. M, molecular weight marker VIX (Roche Diagnostic); 1, ovary; 2, oviduct; 3, testis.

 
Spatial localization of fRLX mRNA
To obtain an overall view of fRLX localization in situ hybridization experiments were carried out on frog testis using DIG-labeled sense and antisense RNA as a probe. The assays were carried out on March testis, when the fRLX expression is at its highest level and on September testis, when the fRLX expression is at its lowest level. A strong signal was detected only in the interstitial tissue around the germinal compartment in March (Fig. 7AGo), whereas a weak interstitial signal was present in the September testis (Fig. 7BGo). No signal was detected in March sense-treated testis (Fig. 7CGo).



View larger version (56K):
[in this window]
[in a new window]
 
Figure 7. In situ hybridization of fRLX antisense mRNA in the testes of March (A) and September (B); fRLF sense probe (C). I, Interstitium; SPZ, spermatozoa. Magnification, A, B, and C, 250x.

 
Cellular localization of fRLX mRNA
To ascertain the specific interstitial cellular type expressing fRLX, we performed in situ hybridization on frog testis treated with EDS, an alchilating agent which has a selective cytotoxic effect on Leydig cells in some mammalian species and in the frog Rana esculenta (25). Leydig cells are destroyed after a single EDS injection and regenerate after 28 days. No fRLX mRNA signal was detected on day 4 after the EDS injection (Fig. 8AGo) when Leydig cells are affected, whereas a strong fRLX mRNA signal reappeared in the interstitial compartment on day 28 when a new population of Leydig cells appear in the interstitial compartment after 28 days (Fig. 8BGo).



View larger version (76K):
[in this window]
[in a new window]
 
Figure 8. In situ hybridization of fRLX antisense mRNA in the frog testes on day 4 (A) and on day 28 (B) after a single injection of EDS. Magnification, A and B, 170x.

 
Pituitary control on the fRLX expression
To determine the pituitary action on fRLX expression in situ hybridization was performed on testes of hypophysectomized (PDX) frogs kept in captivity for 30 days. As control, we used testes of intact animals. The hybridization signal was present in the interstitial compartment of both groups, but it was stronger in the interstitium of the intact animals (Fig. 9Go, A and B). The testis of PDX animals shows the typical characteristic of hypophysectomy: the interstitial compartment becomes hypertrophic, whereas the germinal compartment showed signs of degeneration, such as seminiferous tubules without spermatids (SPT), and very few secondary spermatogonia (II SPG), whereas secondary spermatocytes (II SPC) were rare. Many degenerating nests containing primary spermatocytes (I SPC) were observed.



View larger version (79K):
[in this window]
[in a new window]
 
Figure 9. In situ hybridization of fRLX antisense mRNA in the hypophysectomized frog testes (A) and in the control frog testes (B). After the hybridization the sections were stained with hematoxylin/eosin. I, interstitium; II SPG, secondary spermatogonia; I SPC, primary spermatocytes; II SPC, secondary spermatocytes; SPT, spermatids; SPZ, spermatozoa; arrows, primary spermatogonia; stars, degenerating nets. Magnification: A, x320; B, x250.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the present paper, we report the isolation of a frog relaxin/insulin family member (fRLX) cDNA and the characterization of the spatial expression of the corresponding transcript. The homology between fRLX and other proteins in this family is based on the primary amino acid sequence, considering their characteristic functional domain arrangements, and on the six conserved cysteins residues, necessary to create the inter and intrachain disulphide linkage, characteristic of other relaxin-insulin family members (26). The prepropolypeptide structure, shared by most members of the family, consists of the signal peptide and B, C, and A domains located at N- and C-terminus respectively; a post transcriptional modification produces the removal of the signal peptide and of the C domain (27). The fRLX prepropolypeptide has a modest homology to the mammalian RLFs and relaxins; furthermore, restricted sequence comparison between B and A domains revealed a higher homology [40% and 30.8% to B and A domains of mouse RLF (3), 50% and 41.7% to B and A domains of marsupial relaxin (28)]. The C domain sequence diverged greatly among family proteins and showed no similarity to any known proteins. This diversity could be due to a lack of selection pressure in this region.

fRLX protein, similar to the mammalian RLF and the other relaxin known proteins, contains a conserved amino acid motif, R-XXX-R, close to the first cystein of the B domain. Because this motif has been shown to be important for relaxin binding to its putative receptor in many tissues (29, 30, 31), it has been hypothesized that the relaxin receptor could be recognized by RLF with lower affinity (32). Alteration of basic residues in this binding motif completely abolished receptor interaction (29, 33, 34).

The phylogenetic tree for amino acid sequences related to RLF and relaxin proteins suggests that fRLX may be grouped with shark and mammalian relaxins. It is to be noted that fRLX, as the mammalian RLFs, is highly expressed in the testicular Leydig cells and lowly expressed in the ovary and in the female tract, whereas mammalian relaxins are classical endocrine hormones, produced by the ovary, and targeting the reproductive system to ripen the cervix, elongate the pubic symphysis and inhibit uterine contraction (35, 36).

Taken together, our results with phylogenetic analysis evidenced that fRLX sequence can represent an ancestral form of relaxin from which both modern mammalian relaxin and RLF might have evolved, respectively, for female and male functions.

The frog testis fRLX mRNA is a specific transcript found in the interstitial compartment and absent in the tubular compartment. Analyses of the Northern blot revealed a different expression of the transcript throughout the year. fRLX mRNA is more abundant in January and February. It reaches a peak in March-April then gradually declines from May onwards with a minimum in September-October. It is of interest to remember that circulating levels of androgens in Rana esculenta are relatively high when fRLX mRNA is more abundant (37). At the same time, androgens are necessary for spermatogonial proliferation and spermatid formation. Therefore, fRLX expression pattern correlates well with the frog steroidogenic and spermatogenetic wave.

It has been hypothesized that mouse RLF is a testicular factor that plays an essential role in testis descent, which is involved in gubernacolum development (15, 16) thus making the testis avail a slightly lower (compared with body) temperature threshold necessary for active spermatogenesis. These studies also mentioned that RLF knockout mice show abnormal spermatogenesis. However, normal spermatogenesis was observed in the surgically descended testis of RLF-deficient mice, strongly suggesting that in mice, RLF is not essential for germ cell development (15). In lower vertebrates, like the frog, where testicular descent does not occur, spermatogenesis is susceptible to seasonal thermal influence (17). The fact that the seasonal pattern of fRLX expression is consistent with seasonal testicular cycle strongly suggests a role of this factor in testicular activity.

In an attempt to obtain more information about the hypophysial influences on fRLX expression, if any, we investigated the presence of fRLX transcript in the testes of PDX animals after 30 days from surgical depletion. The fRLX expression was detected at a lower level in the interstitial compartment of the PDX frogs compared with that of the intact animals. This preliminary result seems to indicate that the fRLX expression could be under hypophysal control. A pituitary control of RLF expression has been indicated using hypogonadic mice lacking an active pituitary-gonadal axis caused by a deletion in the hypothalamically expressed gene for GnRH with consequent gonadotropin deficiency (38, 39, 40) in which RLF expression is totally absent, suggesting that Leydig cells seems to be arrested in a prepubertal state of differentiation (41).

In conclusion, our present study is the first report on the isolation and characterization of a new member of the relaxin/insulin family in a nonmammalian vertebrate, the frog Rana esculenta. EDS administration showed that Leydig cells are the specific interstitial cell type expressing fRLX. Its expression changes during the spermatogenetic cycle, suggesting that it might contribute to the efficiency of spermatogenesis in these species with seasonal breeding and it seems to be modulated by pituitary. In addiction, fRLX is expressed at a very low level also in the ovary and oviduct. fRLX may be considered a new marker for the study of the testicular activity in the frog Rana esculenta.


    Acknowledgments
 
We thank Dr. I. D. Morris (Edinburgh, UK) for EDS gift and Dr. G. Procaccini of the Stazione Zoologica "A. Dohrn" for his kind help in the construction of the phylogenetic tree.


    Footnotes
 
1 This work was supported by MURST (ex 40% "Geremia") and Target Project on Biotechnology within the CNR grants. The EMBL/DDBJ/GeneBank accession no. for frog RLX is AJ298874. Back

2 All the authors contributed equally in the preparation of the manuscript. Back

Received December 27, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Adham IM, Burkhardt E, Benahmed M, Engel W 1993 Cloning of a cDNA for a novel insuline-like peptide of the testicular Leydig cells. J Biol Chem 268:26668–26672[Abstract/Free Full Text]
  2. Burkhardt E, Adham IM, Hobohm U, Murphy D, Sander C, Engel W 1994 A human cDNA coding for a Leydig insulin-like peptide (Ley-I-L). Hum Genet 94:91–94[CrossRef][Medline]
  3. Pusch W, Balvers M, Ivell R 1996 Molecular cloning and expression of the relaxin-like factor from the mouse testis. Endocrinology 137:3009–3013[Abstract]
  4. Gyesik M, Sherwood OD 1998 Localization of specific relaxin-binding cells in the ovary and testis of pigs. Biol Reprod 59:401–409[Abstract/Free Full Text]
  5. Burkhardt E, Adham IM, Brosig B, Gastmann A, Mattei MG, Engel W 1994 Structural organization of the porcine and human genes coding for a Leydig cell-specific insulin-like peptide (Ley-I-L) and chromosomal localization of the human gene (INSL 3). Genomics 20:13–19[CrossRef][Medline]
  6. Hombach-Klonisch S, Tetens F, Kauffold J, Steger K, Fischer B, Klonisch T 1999 Molecular cloning and localization of caprine relaxin-like factor (RLF) mRNA within the goat testis. Mol Reprod Dev 53:135–141[CrossRef][Medline]
  7. Zarreh-Hoshyari-Khah MR, Einspanier A, Ivell R 1999 Differential splicing and expression of the relaxin-like factor gene in reproductive tissues of the marmoset monkey (Callithrix jacchus). Biol Reprod 60:445–453[Abstract/Free Full Text]
  8. Zimmermann S, Schöttler P, Engel W, Adham IM 1997 Mouse Leydig insulin-like (Ley-I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev 47:30–38[CrossRef][Medline]
  9. Ivell R 1997 Biology of the relaxin-like factor (RLF). Rev Reprod 2:133–138[Abstract]
  10. Tashima LS, Hieber AD, Greenwood FC, Bryant-Greenwood GD 1995 The human Leydig insulin-like (Ley-I-L) gene is expressed in the corpus luteum and trophoblast. J Clin Endocrinol Metab 80:707–710[Abstract]
  11. Bathgate RAD, Balvers M, Hunt N, Ivell R 1996 Relaxin-like factor gene is highly expressed in the bovine ovary of the cycle and pregnancy: sequence and messenger ribonucleic acid analysis. Biol Reprod 55:1452–1457[Abstract]
  12. Roche PJ, Crawford RJ, Tregear GW 1993 A single copy relaxin-like gene sequence is present in sheep. Mol Cell Endocrinol 91:21–28[CrossRef][Medline]
  13. Zimmermann S, Schwärzler A, Buth S, Engel W, Adham IM 1999 Transcription of the Leydig insulin-like gene is mediated by steroidogenic factor-1. Mol Endocrinol 12:706–713[Abstract/Free Full Text]
  14. Adham IM, Zimmermann S, Engel W 1997 Leydig insulin-like hormone-deficient mice show premeiotic arrest and germ cell death. Reprod Domest Anim 32:73
  15. Zimmermann S, Steding G, Emmen JMA, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM 1999 Targeted distruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13:681–691[Abstract/Free Full Text]
  16. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295–299[CrossRef][Medline]
  17. Rastogi RK, Iela L 1992 Spermatogenesis in amphibia: dynamics and regulation. In: Dellai R (ed) Sex Origin and Evolution. Mucchi, Modena, pp 231–249
  18. Sprenger H, Konrad L, Rischowsky E, Gemsa D 1995 RNA extraction from gastrointestinal tract and pancreas by a modified Chomczynski and Sacchi method. Biotechniques 19:340–343[Medline]
  19. Sambroock J, Fritsch EF, Maniatis T 1989 Molecular Cloning. A Laboratory Manual, ed 2. Cold Spring Harbor Laboratory Press, New York
  20. Aniello F, Branno M, Marra P, Chieffi-Baccari G, Di Matteo L, Minucci S 1996 Molecular cloning of a novel mRNA (Harderin) specifically and highly expressed in the Harderian gland of the frog Rana esculenta. Biochem Mol Biol Int 38:401–408[Medline]
  21. Sanger F, Nicklen S, Coulson AR 1975 A rapid method for determine sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol 94:441–445[CrossRef][Medline]
  22. Hall TA 1999 BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
  23. Felsenstein J 1989 PHYLIP: Phylogeny Interference Package, Ver 3.4. Cladistics 5:164–166
  24. Rastogi RK, Chieffi G 1972 Hypotalamic control of the hypophyseal gonadotropic function in the adult male green frog, Rana esculenta. J Exp Zool 181:263–270[Medline]
  25. Minucci S, Fasano S, Pierantoni R 1992 The use of EDS in investigation of the testicular activity in vertebrates. In: Alexander JC (ed) Advances in Comparative Endocrinology. Compilers International, Bangalore-Varanesi-Texas, 1:117–125
  26. Blindell TL, Humbel RE 1980 Hormone families: pancreatic hormones and homologous growth factors. Nature 187:781–787
  27. Steiner DF 1998 The protein convertases. Curr Opin Chem Biol 2:31–39[CrossRef][Medline]
  28. Parry LJ, Rust W, Ivell R 1997 Marsupial relaxin: complementary deoxyribonucleic acid sequence and gene expression in the female and male tammar wallaby, Macropus eugeii. Biol Reprod 57:119–127[Abstract]
  29. Bullesbach EE, Yang S, Schwabe C 1992 The receptor-binding site of human relaxin II. J Biol Chem 267:22957–22960[Abstract/Free Full Text]
  30. Eigenbrot C, Randal M, Quan C, Burnier J, O’Connell L, Rinderknecht E, Kossiakoff AA 1991 X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants. J Mol Biol 221:15–21[Medline]
  31. Bullesbach EE, Schwabe C 1988 On the receptor binding site of relaxins. Int J Pept Protein Res 32:361–367[Medline]
  32. Sherwood OD, Downing SJ, Guico-Lamm ML, Hwang JJ, O’Day-Bowman MB, Fields PA 1993 The physiological effects of relaxin during pregnancy: studies in rats and pigs. Oxf Rev Reprod Biol 15:143–189[Medline]
  33. Bullesbach EE, Schwabe C 1995 A novel Leydig cells cDNA-derived protein is a relaxin-like factor. J Biol Chem 270:16011–16015[Abstract/Free Full Text]
  34. Schwabe C, Bullesbach EE 1985 Relaxin: structures, functions, promises and non-evolution. FASEB J 8:1152–1160[Abstract]
  35. Bryant-Greenwood GD, Schwabe C 1994 Human relaxin: chemistry and biology. Endocr Rev 15:5–26[CrossRef][Medline]
  36. Sherwood OD 1994 Relaxin. In: Knobil E, Neill JD (eds) Physiology of Reproduction. Academic Press, New York, pp 861–1009
  37. Varriale B, Pierantoni R, Di Matteo L, Minucci S, Fasano S, D’Antonio M, Chieffi G 1986 Plasma and testicular estradiol and plasma androgen profile in the male frog. Rana esculenta, during the annual cycle. Gen Comp Endocrinol 64:401–404[CrossRef][Medline]
  38. Scott IS, Charlton HM, Cox BS, Grocock CA, Sheffield JW, O’Shaughnessy PJ 1990 Effect of LH injections on testicular steroidogenesis, cholesterol side-chain cleavage P450 mRNA content and Leydig cell morphology in hypogonadal mice. J Endocrinol 125:131–138[Abstract/Free Full Text]
  39. Cattenach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G 1997 Gonadotropin releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338–340
  40. Charlton HM, Halpin DMG, Iddon C, Rosie R, Levy G, McDowell IFW, Megson A, Morris JF, Bramwell A, Speight A, Ward BJ, Broadhead J, Davey-Smith G, Fink G 1983 The effect on daily administration of single and multiple injection of gonadotropin releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. Endocrinology 113:535–544[Medline]
  41. Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E, Mukhopadhyay AK, Hanks E, Charlton M, Ivell R 1998 Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 139:2960–2970[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Exp. Biol.Home page
G. De Rienzo, F. Aniello, M. Branno, G. Izzo, and S. Minucci
The expression level of frog relaxin mRNA (fRLX), in the testis of Rana esculenta, is influenced by testosterone
J. Exp. Biol., October 1, 2006; 209(19): 3806 - 3811.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Ivell and R. A.D. Bathgate
Reproductive Biology of the Relaxin-Like Factor (RLF/INSL3)
Biol Reprod, September 1, 2002; 67(3): 699 - 705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. D. Bathgate, C. S. Samuel, T. C. D. Burazin, S. Layfield, A. A. Claasz, I. G. T. Reytomas, N. F. Dawson, C. Zhao, C. Bond, R. J. Summers, et al.
Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene. NOVEL MEMBERS OF THE RELAXIN PEPTIDE FAMILY
J. Biol. Chem., January 4, 2002; 277(2): 1148 - 1157.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Rienzo, G.
Right arrow Articles by Minucci, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Rienzo, G.
Right arrow Articles by Minucci, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals